Age-associated Toxicity
Age-associated Toxicity - Related Videos
13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
0 Views •
Cited by 76 •
2010
The intensely studied nematode worm Caenorhabditis elegans can be transgenically engineered to express the human β-amyloid peptide (Aβ). Induced expression of Aβ in C. elegans muscle leads to a rapid, reproducible paralysis phenotype that can be used to monitor treatments that modulate Aβ toxicity.
09:14
An Introduction to Aging and Regeneration
0 Views •
2023
Tissues are maintained through a balance of cellular aging and regeneration. Aging refers to the gradual loss of cellular function, and regeneration is the repair of damaged tissue generally mediated by preexisting adult or somatic stem cells. Scientists are interested in understanding the biological mechanisms behind these two complex processes. By doing so, researchers may be able to use somatic stem cells to treat degenerative diseases and develop therapies that could delay the effects of...
10:41
Continuous High-resolution Microscopic Observation of Replicative Aging in Budding Yeast
0 Views •
Cited by 10 •
2013
We describe here the operation of a microfluidic device that allows continuous and high-resolution microscopic imaging of single budding yeast cells during their complete replicative and/or chronological lifespan.
09:06
Growth Assays to Assess Polyglutamine Toxicity in Yeast
0 Views •
Cited by 3 •
2012
This manuscript describes three complementary protocols for assessing the toxicity of polyglutamine (polyQ)-expansion proteins in the yeast Saccharomyces cerevisiae. These protocols can easily be modified to monitor the toxicity of other misfolded proteins in yeast.
09:10
Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
0 Views •
2026
The protocol presents the imaging and computational workflow to extract and validate imaging-based chromatin and epigenetic age (ImAge).
FAQs
Age-associated toxicity can intensify when aging slows drug metabolism and clearance. Reduced performance of detoxifying organs may prolong exposure, while weaker tissue repair and antioxidant defenses leave damage less effectively corrected. These changes can allow harmful effects to accumulate even when the administered chemical or drug is unchanged, making age an essential biological variable in toxicity studies.
Researchers can compare aged and younger biological systems while examining responses across dose levels. A consistent difference between age groups at the same exposure supports an age-related contribution, whereas the dose-response pattern shows how harm changes as exposure increases. Using both comparisons helps prevent age-related susceptibility from being mistaken for a chemical’s exposure effect.
Disruption of cellular homeostasis can make it harder for older cells to maintain normal internal conditions during stress. At the same time, reduced antioxidant defenses may limit control of damaging processes, and impaired repair can leave injury unresolved. Together, these age-related changes help explain persistent or accumulating toxicity after biological stressors or chemical exposure.
Studies can use aged cells, tissue cultures, or animal models to examine how aging modifies harmful responses. Dose-response measurements then provide a structured way to relate exposure level to observed toxicity in each system. Combining model choice with these measurements helps researchers evaluate effects at cellular, tissue, or organismal levels rather than relying on exposure data alone.
Dose-response measurements show how toxic effects change as exposure increases and whether that pattern differs between biological systems of different ages. An age-related shift in observed responses indicates that susceptibility is not determined by exposure level alone. This comparison supports more accurate interpretation of experimental results and helps distinguish biological vulnerability from the direct effect of the tested agent.
Age-associated toxicity provides a basis for testing whether drug-related or environmental harms are amplified by age-related changes in physiology. Findings from aged cells, tissue cultures, or animal models can improve risk assessment and reveal responses that younger systems may not represent. This evidence also supports safer drug development and treatments tailored to age-related physiological changes.